CME vs CPIX · P/E 22, rev $6.52B vs rev $10.4M
CME Group Inc (CME) versus Cumberland Pharmaceuticals Inc (CPIX) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. CPIX currently screens at market cap $86.9M.
Not investment advice. Open the CME and CPIX stock pages for the full models.
Not investment advice.